Published in Indian J Pharm Sci on November 01, 2011
An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med (2006) 5.02
Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity. Clin Infect Dis (2010) 3.71
A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience. Pharmacoepidemiol Drug Saf (2006) 2.69
Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome. Hepatology (2010) 1.98
Antituberculosis drugs and hepatotoxicity. Respirology (2006) 1.62
Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg (1995) 1.45
Drug-induced liver injury: is it somehow foreseeable? World J Gastroenterol (2009) 1.18
Fulminant hepatic failure caused by tuberculosis. Gut (1995) 1.18
Biochemical and cellular mechanisms of toxic liver injury. Semin Liver Dis (2002) 1.14
Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study. J Pediatr Gastroenterol Nutr (2011) 1.12
Classification, etiology, and considerations of outcome in acute liver failure. Semin Liver Dis (1996) 1.07
Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies. BMC Public Health (2008) 1.03
Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: in vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis (2005) 1.03
Frequency of anti-tuberculous therapy-induced hepatotoxicity in patients and their outcome. J Ayub Med Coll Abbottabad (2010) 0.90
Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach. World J Gastroenterol (2008) 0.90
Protective effect of Tinospora cordifolia, Phyllanthus emblica and their combination against antitubercular drugs induced hepatic damage: an experimental study. Phytother Res (2008) 0.89
Hepatotoxicity due to antituberculosis therapy. Clinical profile and reintroduction of therapy. J Clin Gastroenterol (1996) 0.85
Rifampicin-isoniazid induced fatal fulminant hepatitis during treatment of latent tuberculosis: A case report and literature review. Indian J Crit Care Med (2010) 0.80
Assessment of protective role of polyherbal preparation, Livina, against anti-tubercular drug induced liver dysfunction. Indian J Exp Biol (2010) 0.79
[Study on liver damage caused by anti-TB drug intermittent treatment on patients with HBV-TB co-infection]. Zhonghua Liu Xing Bing Xue Za Zhi (2009) 0.78
An uncommon catastrophe associated with methotrexate. J Postgrad Med (2011) 0.75
A fluke occurrence of paramount significance. J Postgrad Med (2011) 0.75